Taken together, we identified five hub genes, namely, PTPRC, CD53, IRF8, IL10RA, and LAPTM5, as potential biomarkers for the diagnosis and treatment of DN and revealed the mechanism of DN at the transcriptome level. Here, LAPTM5 is linked to liver dysplastic nodule.